Allopurinol treatment changes microglial characteristics in neonatal mice
Related Experiment Video
Updated: Sep 10, 2025
Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
Rin-Ichiro Teruya1, Tomomi Okajima-Takahashi2, Fuminori Tsuruta3,4,5,6
1Doctoral Program in Biology, Degree Programs in Life and Earth Sciences, Graduate School of Science and Technology, University of Tsukuba, Tsukuba, Japan.
Abstract:
Microglia are resident immune cells that play crucial roles in regulating brain development. During the pre and postnatal stage, microglial morphology gradually alters by the elongation of processes and an increase in the number of branches. Previously, we reported that hypoxanthine, a key intermediate of the purine metabolism, affects the morphology of microglial cell line BV2. In this study, we show that administration of allopurinol, an inhibitor of xanthine oxidase, changes microglial morphology in vivo . We found that the number of branches and summed length of processes are increased in allopurinol-treated microglia in a sex-independent manner. Notably, allopurinol administration altered the number of IBA1-positive microglia in male mice. These findings suggest that purine metabolism contributes to the regulation of microglial characteristics during neonatal brain development.
Insights
Allopurinol, a xanthine oxidase inhibitor, alters microglial morphology during neonatal brain development. This suggests purine metabolism influences microglial characteristics, impacting brain development.
Area of Science:
- Neuroscience
- Immunology
- Developmental Biology
Background:
- Microglia are crucial for brain development, with their morphology changing during pre- and postnatal stages.
- Purine metabolism, specifically hypoxanthine, has been previously shown to affect microglial cell line BV2 morphology.
- Understanding microglial regulation is key to understanding neonatal brain development.
Purpose of the Study:
- To investigate the in vivo effects of allopurinol, a xanthine oxidase inhibitor, on microglial morphology.
- To determine if purine metabolism influences microglial characteristics during neonatal brain development.
Main Methods:
- Administration of allopurinol to mice during the neonatal period.
- Analysis of microglial morphology, including branch number and process length.
- Quantification of IBA1-positive microglia in different sexes.
Main Results:
- Allopurinol administration increased the number of branches and summed length of processes in microglia in a sex-independent manner.
- A notable alteration in the number of IBA1-positive microglia was observed in male mice treated with allopurinol.
- These morphological changes suggest a role for purine metabolism in microglial regulation.
Conclusions:
- Purine metabolism significantly contributes to the regulation of microglial characteristics during neonatal brain development.
- Allopurinol's impact on microglial morphology highlights the link between purine metabolism and immune cell development in the brain.
- Further research into purine metabolism pathways could reveal novel therapeutic targets for neurodevelopmental disorders.
